Abstract

In the large majority of previous studies, patients with a history of acute urticaria induced by nonsteroidal anti-inflammatory drugs (NSAIDs) seeking safe alternative drugs have undergone tolerance tests uniquely with compounds exerting little or no inhibitory effect on the cyclooxygenase 1 enzyme. In light of recently published studies, however, this approach seems inadequate and should be changed. The present article critically reviews the clinical management of patients presenting with a history of urticaria induced by a single NSAID or multiple NSAIDs and suggests a simple, updated diagnostic algorithm that may assist clinicians in correctly classifying their patients.

Highlights

  • In the large majority of previous studies, patients with a history of acute urticaria induced by nonsteroidal anti-inflammatory drugs (NSAIDs) seeking safe alternative drugs have undergone tolerance tests uniquely with compounds exerting little or no inhibitory effect on the cyclooxygenase 1 enzyme

  • Their question is ‘‘What can I take in case of headache, pain, or fever?’’ The present article focuses on the clinical management of patients with NSAID-induced urticaria/angioedema in view of recently published literature

  • And to patients with aspirin-exacerbated respiratory disease (AERD), in patients with acute urticaria induced by distinct NSAIDs, cross-reactions occurred mainly among COX-1inhibiting drugs,[13,17] whereas drugs exerting little effect on the cyclooxygenase 1 (COX-1) enzyme[10,11,18,19,20,21,22,23,24] and NSAIDs characterized by different mechanisms of actions or opiate agonists with analgesic activity[9,11,15,25] were generally well tolerated

Read more

Summary

ORIGINAL ARTICLE

Clinical Management of Adult Patients with a History of Nonsteroidal Anti-Inflammatory Drug–Induced Urticaria/ Angioedema: Update. Skin reactions (urticaria/angioedema) are Allergy, Asthma, and Clinical Immunology, Volume 3, Number 1, 2007

Yes Yes No Yes No Yes or No
Diagnostic Workup
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.